UK MHRA promises easier route through regulatory maze for health tech innovations
11 March 2013
- EU regs for drug-device combinations get more complicated – time for a rewrite?
- INTERVIEW: Medtech innovation needs in the UK – who is really listening?
- One-stop regulatory shop: taking a deeper dive into the IMDRF, its agenda and latest news
- Human factors engineering initiative likely to result in guidance, says UK expert
Other Informa News